Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis. Jin J, Hu J, Zhou W, Wang X, Xiao Q, Xue N, Yin D, Chen X Biochem Pharmacol. 2014 Apr 26. PMID: 24780445. Abstract CommentRecommendBookmarkWatch